Discover
SCPH
scPharmaceuticals Inc.
5.67
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 60.17% | |
| 1y | 32.48% |
5.67
day range
5.67
52 week range
| Open | 5.68 | Prev Close | 5.67 | Low | 5.67 | High | 5.67 | Mkt Cap | N/A |
| Vol | 9.24M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -4.68 |
| Beta | N/A | Short Ratio | 11.41 | Inst. Own | 81.64% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 17.50 |
| Income Statement | |||
| Total Revenue | 16.04M | ||
| Revenues (USD) | 16.04M | ||
| Cost of Revenue | 5.01M | ||
| Gross Profit | 11.03M | ||
| Operating Expenses | 25.32M | ||
| Research and Development Expense | 4.10M | ||
| Selling, General and Administrative Expense | 21.23M | ||
| Operating Income | -14.29M | ||
| Interest Expense | 1.40M | ||
| Net Income | -18.02M | ||
| Net Income Common Stock | -18.02M | ||
| Net Income Common Stock (USD) | -18.02M | ||
| Consolidated Income | -18.02M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -16.62M | ||
| Earning Before Interest & Taxes (USD) | -16.62M | ||
| Weighted Average Shares | 53.72M | ||
| Weighted Average Shares Diluted | 53.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 40.81M | ||
| Cash and Equivalents (USD) | 40.81M | ||
| Trade and Non-Trade Receivables | 19.41M | ||
| Current Assets | 78.73M | ||
| Property, Plant & Equipment Net | 1.22M | ||
| Total Assets | 80.26M | ||
| Debt Current | 264.00K | ||
| Total Debt | 81.41M | ||
| Current Liabilities | 20.43M | ||
| Debt Non-Current | 81.14M | ||
| Total Liabilities | 101.57M | ||
| Accumulated Retained Earnings (Deficit) | -404.26M | ||
| Shareholders Equity | -21.32M | ||
| Shareholders Equity (USD) | -21.32M | ||
| Assets Non-Current | 1.53M | ||
| Total Debt (USD) | 81.41M | ||
| Inventory | 14.57M | ||
| Liabilities Non-Current | 81.14M | ||
| Trade and Non-Trade Payables | 4.03M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 64.00K | ||
| Net Cash Flow from Financing | -624.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.73M | ||
| Issuance (Purchase) of Equity Shares | 316.00K | ||
| Issuance (Repayment) of Debt Securities | -940.00K | ||
| Net Cash Flow from Operations | -16.11M | ||
| Share Based Compensation | 1.52M | ||